Cesarean Section

Endometriosis was significantly associated with adverse pregnancy outcomes, ranging from preterm labor and birth to antepartum and postpartum hemorrhage, researchers reported in the Journal of Clinical Medicine.

The 5th U.S. Circuit Court of Appeals has ruled to roll back mifepristone regulations, ending availability via telehealth or mail. However, these restrictions will not go into effect unless they are upheld by the U.S. Supreme Court.

Publication of the ARRIVE trial was linked to a rise in 39-week labor induction rates and a decrease in cesarean birth rates among low-risk nulliparous women, according to a research letter published in JAMA Network Open.

Despite the decreases noted in a recently released CDC report for teenage and preterm birth rates and cesarean section rates, experts highlight the need for continued work in improving maternal and infant health outcomes.

Children born by caesarean section had an increased risk for developing atopic dermatitis before age 5 years compared with children born by vaginal delivery, according to a study published in Pediatric Allergy and Immunology.

More than 40% of healthy mothers recruited for a study testing fecal transplantation for babies born by cesarean section tested positive for potentially harmful pathogens, Finnish researchers reported.

Risk-stratified timed birth at term, either via labor induction or cesarean delivery, may more than halve the risk for at-term preeclampsia, a leading cause of maternal and perinatal mortality and morbidity, researchers reported.

Low-risk cesarean deliveries decreased over the study period, with cesarean deliveries for labor arrest growing less common and those for nonreassuring fetal status increasing, according to study findings.

Administering six vs. two doses of ketorolac for pain management after cesarean delivery was associated with fewer opioid orders within 72 hours postpartum, according to a presenter at The Pregnancy Meeting.

Researchers observed no differences in rates of cesarean delivery among women with prolonged labor who were administered propranolol vs. placebo, findings presented at The Pregnancy Meeting showed.